- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04521166
Hearing Aid Processing and Working Memory in Realistic Spatial Conditions (DIRWDRCWM)
October 3, 2023 updated by: Varsha Rallapalli, Northwestern University
Investigating the Relationship Between Directional Microphones, Compression, and Working Memory in Realistic Spatial Conditions.
The goal of this project is to determine whether the selection of hearing aid settings should be based in part on an individual's cognitive characteristics (specifically, working memory).
We anticipate the outcomes of this study to be applicable to realistic listening conditions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Hearing aids have specialized features to improve access to sounds for the hearing-impaired listener.
The choice of appropriate hearing aid settings is integral to the hearing rehabilitative process.
Researchers and clinicians have been influenced by previous work showing that individual cognitive abilities, including working memory, are associated with hearing aid benefit, especially in adverse listening conditions.
However, previous research is limited to omnidirectional microphone settings and unrealistic listening conditions.
Such conditions fail to recognize that most hearing aids are fit with directional processing that may improve the listening environment, and that typical environments contain speech and noise signals in a range of spatial locations.
Therefore, the broad goal of this research is to understand how patient variables interact with hearing aid signal processing in realistic listening conditions in order to effectively treat hearing-impaired individuals in communications situations that are most important to them.
Study Type
Interventional
Enrollment (Actual)
61
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Evanston, Illinois, United States, 60208
- Northwestern University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- > =18 years of age; any sex
- Sensorineural hearing loss with pure-tone thresholds between 25-70 decibel hearing level (dB HL) at octave frequencies between 250 and 3000 Hz
- Speak English as their primary language
- Normal or corrected-to-normal vision (<=20/50)
- Participants will be in good health (self-report)
Exclusion Criteria:
- Clinically significant unstable or progressive medical conditions
- Participants who score < 23 on the cognitive screening test (Montreal Cognitive Assessment)
- Evidence of conductive hearing loss or middle ear issues
- Significant history of otologic or neurologic disorders
- Evidence of significant asymmetry between ears
- Non-English-speaking or non-native English speaking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Setting 1
Hearing aid features presented in this arm include omnidirectional microphone settings and fast-acting compression
|
Settings in a wearable hearing aid will be adjusted within a clinically-relevant range for two features.
The features include wide dynamic range compression and microphone directionality.
|
Experimental: Setting 2
Hearing aid features presented in this arm include omnidirectional microphone settings and slow-acting compression
|
Settings in a wearable hearing aid will be adjusted within a clinically-relevant range for two features.
The features include wide dynamic range compression and microphone directionality.
|
Experimental: Setting 3
Hearing aid features presented in this arm include directional microphone settings and fast-acting compression
|
Settings in a wearable hearing aid will be adjusted within a clinically-relevant range for two features.
The features include wide dynamic range compression and microphone directionality.
|
Experimental: Setting 4
Hearing aid features presented in this arm include directional microphone settings and slow-acting compression
|
Settings in a wearable hearing aid will be adjusted within a clinically-relevant range for two features.
The features include wide dynamic range compression and microphone directionality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Speech intelligibility (percent correct scores)
Time Frame: 1 day
|
Listeners will listen to and repeat recorded low-context sentences mixed with noise from different spatial locations.
Speech intelligibility will be measured immediately following hearing aid fitting.
Scoring is determined by percentage of words repeated correctly.
Scores range from 0-100% (higher score indicates better performance).
This task may take up to 1-2 visits (~ 2 hours each) for different combinations of hearing aid features.
The device will only be worn in the laboratory for the duration of the experimental task and will be retrieved by the investigator at the end of each visit.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Varsha Rallapalli, AuD, PhD, Northwestern University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 6, 2021
Primary Completion (Actual)
June 29, 2023
Study Completion (Actual)
June 29, 2023
Study Registration Dates
First Submitted
August 17, 2020
First Submitted That Met QC Criteria
August 19, 2020
First Posted (Actual)
August 20, 2020
Study Record Updates
Last Update Posted (Actual)
October 5, 2023
Last Update Submitted That Met QC Criteria
October 3, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00210459
- K01DC018324 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Sensorineural
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
-
CochlearCompletedUnilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis) | Sensorineural Hearing Loss, Unilateral With Normal Hearing on the Contralateral SideCanada
-
Fundación Pública Andaluza para la gestión de la...RecruitingBilateral Sensorineural Hearing Loss | Unilateral Sensorineural Hearing LossSpain
-
University College, LondonUnknownSensorineural Hearing Loss | Sensory Hearing Loss | Sensorineural Hearing Loss in Left Ear | Sensorineural Hearing Loss in Right Ear | Sensorineural HearingUnited Kingdom
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium
-
Auris Medical, Inc.TerminatedHearing Loss, Idiopathic Sudden SensorineuralUnited States, Korea, Republic of, Canada
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Cochlear Bone Anchored SolutionsCompletedSingle Sided Sensorineural Deafness | Mixed Hearing Loss, UnilateralDenmark, Spain, United Kingdom, Belgium
-
University of Colorado, DenverCompletedSudden Sensorineural Hearing Loss (SSNHL)United States
Clinical Trials on Hearing aid
-
Northwestern UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
Sonova AGCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralCanada
-
Bernafon AGCompletedHearing LossSwitzerland
-
Sonova AGWestern UniversityRecruiting
-
Sonova AGCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralCanada
-
Sonova AGCompleted
-
Education University of Hong KongChinese University of Hong KongCompletedTinnitus, Subjective | Hearing ImpairmentHong Kong
-
Sonova AGCompleted